Unimax Laboratories Private Limited, a active private limited company, was established on 05 January 1985 in Thane, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24110MH1985PTC035004. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹7.00 M.
Formerly known as Eastern Remedies P Ltd. It upholds a compliant status. Employing 12 professional, Its leadership includes Piyush Suresh Shah (Director), Brijesh Yashwant Shah (Director), Kaushik Ramanlal Shah (Managing Director). Past directors included Yashwant Ramanlal Shah, Suresh Ramanlal Shah, Anil Balkrishna Ghogare. It holds ₹6.75 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at W-50 (B), M.I.D.C. Tarapur, Boisar,, Thane, Maharashtra, 401506.
U24110MH1985PTC035004
035004
05 January 1985
₹1.00 Cr
₹7.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Unimax Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Piyush Suresh Shah | Director | 01 Jul 1999 | Current |
| Brijesh Yashwant Shah | Director | 01 Jul 1999 | Current |
| Kaushik Ramanlal Shah | Managing Director | 01 Jul 1985 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 09 Aug 2024 | Past |
| Pramod Abcsdd | Director | 10 Jun 2015 | Past |
| Pramod Abcsdd | Director | 14 Feb 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Unimax Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.1% increase. The company also saw a substantial improvement in profitability, with a 62.63% increase in profit. The company's net worth Soared by an impressive increase of 26.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Unimax Laboratories had a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹67,459,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2006 | Bank Of Baroda | ₹3.05 Cr | Open |
| 06 Sep 2006 | Bank Of Baroda | ₹3.70 Cr | Open |
Explore comprehensive loan charge details -
Unimax Laboratories has a workforce of 12 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Unimax Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimax Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Unimax Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Unimax Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Bank Of Baroda of Rs. 3.70 Cr registered on 06 Sep 2006 with Charge ID 10101960 was modified on 13 Feb 2014. was documented.
A charge with Bank Of Baroda of Rs. 3.05 Cr registered on 07 Sep 2006 with Charge ID 10107928 was modified on 03 Jan 2011. was recorded as a recent event.
The activity A charge with Bank Of Baroda amounted to Rs. 3.05 Cr with Charge ID 10107928 was registered on 07 Sep 2006. was completed.
Progress on A charge with Bank Of Baroda amounted to Rs. 3.70 Cr with Charge ID 10101960 was registered on 06 Sep 2006. was documented.
The CIN of Unimax Laboratories Private Limited is U24110MH1985PTC035004.
Unimax Laboratories Private Limited is headquartered at W-50 (B), M.I.D.C. Tarapur, Boisar,, Thane, Maharashtra, 401506.
Unimax Laboratories Private Limited was incorporated on 05 January 1985.
The current directors of Unimax Laboratories Private Limited are
The primary industry of Unimax Laboratories Private Limited is Manufacturing.
Unimax Laboratories Private Limited is unlisted.
The authorized capital of Unimax Laboratories Private Limited is ₹1.00 Cr, and the paid-up capital is ₹7.00 M.
The compliance status of Unimax Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX